Table 3 Mean availability of local and imported medicines
Characteristics | % of Local brands (95% CI) | P value | % of Imported brands (95% CI) | P value | |
|---|---|---|---|---|---|
Region | Central-Nakawa | 31.9 (27.0-37.4) | < 0.0001 | 57.0 (51.5–62.4) | < 0.0001 |
South Western-Mbarara | 35.5 (30.2–40.8) | 50.8 (45.4–56.4) | |||
West Nile-Arua | 29.9 (25.0-35.2) | 56.1 (50.5–61.5) | |||
Western-Hoima | 43.2 (37.9–48.8) | 42.6 (37.3–48.2) | |||
Northern-Lira | 36.5 (31.4–42.1) | 57.7 (52.1–63.0) | |||
Eastern-Tororo | 45.2 (39.6–50.7) | 59.2 (53.6–64.5) | |||
South eastern-Jinja | 37.8 (32.5–43.3) | 60.4 (54.8–65.7) | |||
Overall availability | 37.1 (31.9–42.7) | 54.8 (49.3–60.4) | < 0.0001 | ||
VEN classification | Vital | 33.7 (30.3–37.1) | < 0.0001 | 57.4 (54.5–63.1) | |
Essential | 27.9 (25.1–30.7) | 57.4 (54.5–63.1) | |||
Necessary | 55.7 (50.1–61.3) | 43.6 (41.4–48.0) | |||
0.0012 | |||||
Formulation | Tablets/capsules | 35.8 (32.2–39.4) | 0.0011 | 63.9 (60.7–70.3) | |
Oral suspensions/syrups | 21.5 (19.4–23.7) | 61.7 (58.6–67.9) | |||
Parenteral preparations | 54.6 (49.1–60.1) | 23.6 (22.4–26.0) | |||